Sanofi Aventis Company Profile

174, avenue de France		Tel: +33 1 53 77 40 00
F-75013 Paris		Fax: +33 1 53 77 42 96
		IR@sanofi-aventis.com
France		www.sanofi-aventis.com
Europe

Date of Establishment	2004
Employees	101,575
Ticker Symbol	New York: SNY
SIC Codes	2819 2833 2834 2844 2869 3841
Sector	Pharmaceuticals


Sanofi Aventis Principal Activities and Company Overview
Sanofi-Aventis was formed as a result of the acquisition of Aventis by Sanofi-Synth�labo in August 2004. The Company is the third largest pharmaceutical company in the world The Company operates through two business segments:- � Pharmaceutical: comprising six therapeutic areas of Cardiovascular - Thrombosis - Metabolic Disorders - Oncology - Central Nervous System - Internal Medicine. � Vaccines: comprising six areas of Paediatric combination vaccines - Influenza vaccines - Polio vaccines - Adult and Adolescent booster vaccines - Meningitis vaccines - Travel vaccines

Sanofi Aventis Board of Directors
Serge Weinberg, Chairman Chris Viehbacher, Chief Executive Officer Uwe Bicker, Director Robert Castaigne, Director Thierry Desmarest, Director Lord Douro, Director Jean-Ren� Fourtou, Director Claudie Haigner�, Director Igor Landau, Director Suet-Fern Lee, Director Christian Mulliez, Director Lindsay Owen-Jones, Director Carole Piwnica, Director Klaus Pohle, Director G�rard Van Kemmel, Director

Sanofi Aventis Leadership, Senior Decision Makers and Key Executives
� Executive Committee Chris Viehbacher, Chief Executive Officer Olivier Charmeil, Senior Vice President Vaccines J�r�me Contamine, Executive Vice President, Chief Financial Officer Karen Linehan, Senior Vice President, Legal Affairs and General Counsel Philippe Luscan, Senior Vice President Industrial Affairs Roberto Pucci, Senior Vice President, Human Resources Hanspeter Spek, Executive Vice President Pharmaceutical Operations Elias Zerhouni, President, Global R&D � Management Committee Pierre Chancel, Senior Vice President Global Marketing & Access Olivier Charmeil, Senior Vice President Pharmaceutical Operations Asia/Pacific and Japan Philippe Fauchet, Senior Vice President Business Development Bel�n Garijo, Senior Vice President Pharmaceutical Operations Europe and Canada (excluding France) Gregory Irace, Senior Vice President Pharmaceutical Operations United States Michel Labie, Senior Vice President Communications & Institutional and Professional Relations Marie-H�l�ne Laimay, Senior Vice President Audit and Internal Control Assessment Christian Lajoux, Senior Vice President Pharmaceutical Operations France Jean-Pierre Lehner, Senior Vice President, Chief Medical Officer Antoine Ortoli, Senior Vice President Pharmaceutical Operations Intercontinental Philippe Peyre, Senior Vice President Corporate Affairs Wayne Pisano, Senior Vice President Vaccines Jean-Philippe Santoni, Senior Vice President International Development

Full Sanofi Aventis company profile includes*:-
	Selected financial information over 10 years to include revenue, profit before tax, net income, shareholders' equity, total assets, earnings per share and dividends per share
	Sanofi Aventis Full Contact Details
	Sanofi Aventis Analyst Coverage
	Sanofi Aventis snapshot data and quick facts Consolidated and condensed data and quick facts such as revenues by segment, market share, geographical segment information, return on equity, R&D expenditure etc
	Sanofi Aventis List of Competitors
	Sanofi Aventis Board of Directors
	Sanofi Aventis Key Management & Decision Makers
	Sanofi Aventis Executive Biographies
	Sanofi Aventis Activities Overview and Company Background
	Sanofi Aventis Office and Location Directory
	Sanofi Aventis Tradenames
	Sanofi Aventis Date of establishment
	Sanofi Aventis Number of employees
	Sanofi Aventis SIC codes
	Sanofi Aventis Ticker symbol / company type
	* where available